Israel
Companies
Israel's Teva Pharmaceutical Industries has moved to end speculation that it is eying up an acquisition of Germany's Stada Arzneimittel. Teva's North American CEO William Marth stated...
2008-09-22Industry
Israel's Teva Pharmaceutical Industries has announced that it has received EU marketing authorisation for TevaGrastim (filgrastim), a biosimilar of Amgen's Neupogen. Filgrastim is...
2008-09-18Companies
Israel is close to joining the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme (PIC/S), following a successful check of pharmaceutical manufacturing...
2008-08-13Companies
According to Globes [online], a survey by the Manufacturers Association of Israel reported that pharmaceutical exports grew by 44% in Q208 from Q1. The survey also showed that the...
2008-07-24Companies
Not to be outdone by its research-focused rivals, Israel's Teva Pharmaceutical Industries has once again demonstrated its desire to expand by acquisition, launching a US$7.46bn bid...
2008-07-21Companies
Following the rejection of its merger agreement with Israel-based drug manufacturer Taro Pharma , India's Sun Pharma has launched a hostile takeover bid.
2008-07-15Companies
The US FDA has accepted for review Momenta Pharmaceuticals' generic version of Teva Pharmaceutical's Copaxone (glatiramer).
2008-07-15Companies
US-based Mylan has signed an agreement with India's NATCO Pharma to market a generic version of Israeli drugmaker Teva's multiple sclerosis drug Copaxone (glatiramer) in the US, Europe,...
2008-06-12
